Metvian Trio 2mg/500mg/0.2mg Tablet SR
Marketer
Vivichem Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Metvian Trio 2mg/500mg/0.2mg Tablet SR
Triovia 2mg/500mg/0.2mg extended-release tablets are classified as antidiabetic medications. This triple-combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Administer Triovia with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and carry a readily available glucose source (e.g., sugary snacks or juice). Alcohol consumption raises hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any prior heart conditions before initiating treatment, as Triovia may be unsuitable. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Primary Ingredients of Metvian Trio 2mg/500mg/0.2mg Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Metvian Trio 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metvian Trio 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Metvian Trio 2mg/500mg/0.2mg Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Metvian Trio 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metvian Trio 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Metvian Trio 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume on an empty stomach.
How Metvian Trio 2mg/500mg/0.2mg Tablet SR works:
Metvian Trio extended-release tablets (2mg/500mg/0.2mg) combine three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Metvian Trio 2mg/500mg/0.2mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Metvian Trio 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Metvian Trio tablet (2mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Metvian Trio 2mg/500mg/0.2mg SR tablets is likely inadvisable for individuals with kidney impairment and should be forgone. Medical advice is necessary. Furthermore, it's not suggested for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Exercise caution when prescribing Metvian Trio 2mg/500mg/0.2mg SR tablets to individuals with hepatic impairment. Dosage modifications may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate treatment with a reduced Metvian Trio 2mg/500mg/0.2mg SR tablet dose; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Metvian Trio 2mg/500mg/0.2mg Tablet SR :
Should you forget a Metvian Trio 2mg/500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metvian Trio 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently